CTMX 1 (-0.99%)
US23284F1057BiotechnologyBiotechnology

CytomX Therapeutics (CTMX) Stock Highlights

1 | -0.99%
2024-10-30 05:56:54
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. The company focuses on developing Probody therapeutics which addresses clinically-validated cancer targets in immuno-oncology that are difficult to drug and lead to concerns about damage to healthy tissues or toxicities.

Statistics

Range Today
0.99 1.03
Volume Today 724.9K
Range 1 Year
0.99 5.85
Volume 1 Year 555.58M
Range 3 Year
0.99 7.53
Volume 3 Year 1.14B
Range 10 Year
0.99 35
Volume 10 Year 1.76B

Highlights

Market Capitalization 80.46M (small)
Floating Shares 66.34M
Current Price 1
Price To Earnings 7.13
Price To Revenue -0.38
Earnings Per Share 0.15
Payout Ratio 0%

Performance

Latest -0.99%
1 Month -16.67%
3 Months -33.33%
6 Months -37.5%
1 Year -9.09%
3 Years -83.16%
5 Years -84.05%
10 Years -93.75%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.